Galena Stock: What to Watch for

Galena Biopharma  (NASDAQ: GALE  ) announced this morning that it has licensed the rights to sell Zuplenz for $5 million in stock and cash, in addition to royalties, milestones, and an upfront payment.

Galena investors: There are some more important things to focus in on -- and in the video below, Motley Fool health care analysts Michael Douglass and David Williamson lay out what investors interested in Galena should be watching.

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.


Read/Post Comments (2) | Recommend This Article (8)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 07, 2014, at 2:50 PM, Paulson545 wrote:

    Is Erba Diagnostics ( erb ) old headquarters in the Miami Design District worth $1.00 per share in cash ? Read the Yahoo message board for ERB and decide for yourself. Connect the dot's. Legendary investor Dr Phillip Frost built Ivax into a 7 billion dollar company before selling it to Teva Pharma. Ivax than became Erba Diagnostics. There is a world wide diabetes epidemic with over 525 million diabetics by 2025. Ivax, Teva,Erb,OPK, and Dr Frost are all headquartered in the Miami, Florida area.

  • Report this Comment On August 11, 2014, at 3:57 PM, Omar14 wrote:

    Honestly, I don't trust Galena's management team.This company management team in it to make money off the shareholders instead developing products that help the company,management team and it's shareholder. Several months ago when Galen's management hired and paid under the table a reporter to promot Galena's stock ( research and potential products) and it did work based on lies not actual research and potential strong products . As a result the Galen's stock price skyrocted .However, the management team took advantage of it and after the stock price skyrocketed the management team sold their stocks in their own company (Galena) and enrichen theirselves on the expense of Galena's shareholders. I believe they should be investigated by the security and exchange commission.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3039473, ~/Articles/ArticleHandler.aspx, 9/30/2014 10:42:05 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement